Roche Analyst Event at ASCO 2015
Analyst briefing on data presented at ASCO: Sunday, 31 May 2015 6:45 PM CDT
Webcast
Agenda
- Oncology strategy and outlook
Daniel O'Day, Chief Operating Officer Roche Pharmaceuticals - Working along the cancer immunity-cycle: Strategies and new agents
Ira Mellman, gRED: Ph.D., Vice President, Cancer Immunology, Genentech
William Pao, pRED: M.D., Ph.D., Global Head Oncology Discovery and Translational Area, Roche - ASCO 2015 Roche highlights: Setting new standards, developing combinations
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development - Growing importance of molecular information in cancer immunotherapy
Garret Hampton, Ph.D., Vice President, Oncology Biomarker Development and Companion Diagnostics